1 Min Read
Nov 6 (Reuters) - Cytokinetics Inc:
* On Nov 3, entered into controlled equity offering sales agreement to sell shares of common stock, with offering price of up to $75 million Source text : (bit.ly/2znfoQg) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.